The Effect of Tele-Consultation Supported Education After Total Knee Arthroplasty Surgery
Launched by TURGUT SOHRET · Jan 17, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how education and support through tele-consultation can help patients after they have total knee replacement surgery, also known as total knee arthroplasty. Many patients face challenges in their daily activities after this surgery, which can affect their quality of life. The goal of this study is to see if providing nursing education and tele-consultation, guided by a caring approach, can improve how well patients manage daily tasks, take care of themselves, and feel overall better after their surgery.
To participate in this trial, individuals need to be at least 18 years old and scheduled for their first total knee replacement surgery. They should also be able to communicate clearly and have a smartphone with the WhatsApp app installed. The trial is not yet recruiting participants, but it is open to all genders. It's important to note that those undergoing emergency surgeries or those with certain psychiatric disorders will not be eligible. Participants can expect to receive educational support and guidance through phone consultations, which may help them recover more smoothly and improve their quality of life after surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Individuals who voluntarily consent to participate,
- • Aged 18 years or older,
- • Those scheduled for their first Total Knee Arthroplasty (TKA),
- • Patients undergoing unilateral knee prosthesis surgery,
- • Patients without verbal communication barriers for face-to-face and telephone interactions,
- • Patients who own a smartphone and have the WhatsApp application installed.
- Exclusion Criteria:
- • Patients undergoing Total Knee Arthroplasty (TKA) as an emergency surgical intervention,
- • Patients diagnosed with any psychiatric disorder,
- • Patients who wish to withdraw from the study voluntarily,
- • Patients whose communication is interrupted before the completion of the data collection phase.
About Turgut Sohret
Turgut Sohret is a dedicated clinical trial sponsor committed to advancing medical research and innovation through rigorous and ethical study practices. With a focus on developing new therapeutic interventions, Turgut Sohret collaborates with healthcare professionals, regulatory bodies, and research institutions to ensure the highest standards of scientific integrity and patient safety. The organization emphasizes a patient-centric approach, striving to improve health outcomes by facilitating the development of cutting-edge treatments across various medical fields. Through its commitment to excellence, Turgut Sohret plays a pivotal role in enhancing the landscape of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Erzurum, , Turkey
Patients applied
Trial Officials
Turgut Şöhret, PhD student
Study Chair
Turgut ŞÖHRET
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported